Annual CFI
$37.34 M
-$29.85 M-44.43%
December 31, 2023
Summary
- As of February 12, 2025, SYRS annual cash flow from investing activities is $37.34 million, with the most recent change of -$29.85 million (-44.43%) on December 31, 2023.
- During the last 3 years, SYRS annual CFI has fallen by -$9.33 million (-19.99%).
- SYRS annual CFI is now -44.43% below its all-time high of $67.19 million, reached on December 31, 2022.
Performance
SYRS Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$0.00
-$25.07 M-100.00%
September 30, 2024
Summary
- As of February 12, 2025, SYRS quarterly cash flow from investing activities is $0.00, with the most recent change of -$25.07 million (-100.00%) on September 30, 2024.
- Over the past year, SYRS quarterly CFI has dropped by -$28.64 million (-100.00%).
- SYRS quarterly CFI is now -100.00% below its all-time high of $43.20 million, reached on March 31, 2020.
Performance
SYRS Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$1.95 M
-$28.64 M-93.63%
September 30, 2024
Summary
- As of February 12, 2025, SYRS TTM cash flow from investing activities is $1.95 million, with the most recent change of -$28.64 million (-93.63%) on September 30, 2024.
- Over the past year, SYRS TTM CFI has dropped by -$71.59 million (-97.35%).
- SYRS TTM CFI is now -97.35% below its all-time high of $73.54 million, reached on September 30, 2023.
Performance
SYRS TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
SYRS Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -44.4% | -100.0% | -97.3% |
| 3 y3 years | -20.0% | +100.0% | -94.3% |
| 5 y5 years | +450.8% | +100.0% | -94.3% |
SYRS Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -44.4% | +170.9% | -100.0% | +100.0% | -97.3% | +103.7% |
| 5 y | 5-year | -44.4% | +170.9% | -100.0% | +100.0% | -97.3% | +103.7% |
| alltime | all time | -44.4% | +170.9% | -100.0% | +100.0% | -97.3% | +103.7% |
Syros Pharmaceuticals Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $0.00(-100.0%) | $1.95 M(-93.6%) |
| Jun 2024 | - | $25.07 M(-201.7%) | $30.59 M(-20.4%) |
| Mar 2024 | - | -$24.64 M(-1718.9%) | $38.45 M(+3.0%) |
| Dec 2023 | $37.34 M(-44.4%) | $1.52 M(-94.7%) | $37.34 M(-49.2%) |
| Sep 2023 | - | $28.64 M(-13.0%) | $73.54 M(+43.9%) |
| Jun 2023 | - | $32.92 M(-227.9%) | $51.09 M(+50.0%) |
| Mar 2023 | - | -$25.75 M(-168.3%) | $34.05 M(-49.3%) |
| Dec 2022 | $67.19 M(-227.6%) | $37.72 M(+509.2%) | $67.19 M(+129.9%) |
| Sep 2022 | - | $6.19 M(-61.0%) | $29.22 M(+410.3%) |
| Jun 2022 | - | $15.89 M(+115.2%) | $5.73 M(-112.7%) |
| Mar 2022 | - | $7.38 M(-3113.5%) | -$45.01 M(-14.5%) |
| Dec 2021 | -$52.65 M(-212.8%) | -$245.00 K(-98.6%) | -$52.65 M(+0.4%) |
| Sep 2021 | - | -$17.30 M(-50.3%) | -$52.44 M(+47.1%) |
| Jun 2021 | - | -$34.84 M(>+9900.0%) | -$35.66 M(-1214.7%) |
| Mar 2021 | - | -$262.00 K(+803.4%) | $3.20 M(-93.1%) |
| Dec 2020 | $46.66 M(-497.7%) | -$29.00 K(-94.4%) | $46.66 M(-26.7%) |
| Sep 2020 | - | -$522.00 K(-113.0%) | $63.65 M(+805.6%) |
| Jun 2020 | - | $4.01 M(-90.7%) | $7.03 M(-80.3%) |
| Mar 2020 | - | $43.20 M(+154.8%) | $35.70 M(-404.2%) |
| Dec 2019 | -$11.73 M | $16.95 M(-129.7%) | -$11.73 M(+35.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | -$57.14 M(-274.8%) | -$8.65 M(-28.1%) |
| Jun 2019 | - | $32.68 M(-872.8%) | -$12.04 M(-55.8%) |
| Mar 2019 | - | -$4.23 M(-121.1%) | -$27.23 M(+155.9%) |
| Dec 2018 | -$10.64 M(-31.7%) | $20.04 M(-133.1%) | -$10.64 M(-65.4%) |
| Sep 2018 | - | -$60.53 M(-446.2%) | -$30.75 M(-1670.4%) |
| Jun 2018 | - | $17.48 M(+41.4%) | $1.96 M(-136.7%) |
| Mar 2018 | - | $12.36 M(<-9900.0%) | -$5.33 M(-65.8%) |
| Dec 2017 | -$15.59 M(-43.0%) | -$69.00 K(-99.8%) | -$15.59 M(-61.8%) |
| Sep 2017 | - | -$27.82 M(-372.9%) | -$40.86 M(+209.1%) |
| Jun 2017 | - | $10.19 M(+384.7%) | -$13.22 M(-44.3%) |
| Mar 2017 | - | $2.10 M(-108.3%) | -$23.71 M(-13.3%) |
| Dec 2016 | -$27.34 M(+2225.0%) | -$25.33 M(>+9900.0%) | -$27.34 M(+1088.3%) |
| Sep 2016 | - | -$181.00 K(-40.1%) | -$2.30 M(-18.8%) |
| Jun 2016 | - | -$302.00 K(-80.2%) | -$2.83 M(+9.2%) |
| Mar 2016 | - | -$1.52 M(+420.5%) | -$2.59 M(+120.5%) |
| Dec 2015 | -$1.18 M(+485.1%) | -$293.00 K(-58.8%) | -$1.18 M(+33.2%) |
| Sep 2015 | - | -$712.00 K(+1030.2%) | -$883.00 K(+416.4%) |
| Jun 2015 | - | -$63.00 K(-41.7%) | -$171.00 K(+58.3%) |
| Mar 2015 | - | -$108.00 K | -$108.00 K |
| Dec 2014 | -$201.00 K | - | - |
FAQ
- What is Syros Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Syros Pharmaceuticals?
- What is Syros Pharmaceuticals annual CFI year-on-year change?
- What is Syros Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Syros Pharmaceuticals?
- What is Syros Pharmaceuticals quarterly CFI year-on-year change?
- What is Syros Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Syros Pharmaceuticals?
- What is Syros Pharmaceuticals TTM CFI year-on-year change?
What is Syros Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of SYRS is $37.34 M
What is the all time high annual CFI for Syros Pharmaceuticals?
Syros Pharmaceuticals all-time high annual cash flow from investing activities is $67.19 M
What is Syros Pharmaceuticals annual CFI year-on-year change?
Over the past year, SYRS annual cash flow from investing activities has changed by -$29.85 M (-44.43%)
What is Syros Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of SYRS is $0.00
What is the all time high quarterly CFI for Syros Pharmaceuticals?
Syros Pharmaceuticals all-time high quarterly cash flow from investing activities is $43.20 M
What is Syros Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, SYRS quarterly cash flow from investing activities has changed by -$28.64 M (-100.00%)
What is Syros Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of SYRS is $1.95 M
What is the all time high TTM CFI for Syros Pharmaceuticals?
Syros Pharmaceuticals all-time high TTM cash flow from investing activities is $73.54 M
What is Syros Pharmaceuticals TTM CFI year-on-year change?
Over the past year, SYRS TTM cash flow from investing activities has changed by -$71.59 M (-97.35%)